You have 1 free disease view remaining today. Register for more view, it is 100% free →
McCune Albright syndrome
ICD-10 Codes
Related ICD-10:
Description
McCune-Albright Syndrome: A Rare Genetic Disorder
McCune-Albright syndrome (MAS) is a rare genetic disorder that affects the bones, skin, and endocrine system. The condition is characterized by three main features:
- Polyostotic fibrous dysplasia: This feature involves the growth of abnormal fibrous tissue in multiple bones, leading to bone deformities and pain.
- Café-au-lait skin pigmentation: People with MAS often have light-brown birthmarks or patches on their skin, which can vary in size and number.
- Early onset of puberty: MAS can cause the early onset of puberty, particularly in girls, due to an overproduction of hormones.
The symptoms of MAS can range from mild to severe and may include:
- Light-brown birthmarks or patches on the skin
- Fibrous tissue growths in the bones
- Early onset of puberty (in girls)
- Bone deformities and pain
- Other endocrine system abnormalities
According to [5], MAS is a genetic condition that affects at least two of these three features. The exact cause of MAS is unknown, but it is believed to be related to mutations in the GNAS gene.
MAS can have significant effects on an individual's quality of life, particularly if left untreated or misdiagnosed. Early diagnosis and treatment are essential for managing the symptoms and preventing complications [9].
References:
- [1] McCune-Albright syndrome: A rare genetic disorder affecting bones, skin, and endocrine system.
- [5] MAS consists of at least two of the following three features: polyostotic fibrous dysplasia, café-au-lait skin pigmentation, and early onset of puberty.
- [9] MAS symptoms can vary from mild to severe, and may include light-brown birthmarks, fibrous tissue in the bones, and early onset of puberty.
Additional Characteristics
- Polyostotic fibrous dysplasia
- Café-au-lait skin pigmentation
- Early onset of puberty
Signs and Symptoms
McCune-Albright Syndrome (MAS) Signs and Symptoms
McCune-Albright syndrome is a rare genetic disorder that affects the bones, skin, and hormone-producing tissues. The signs and symptoms of MAS can vary in severity and may include:
- Bone abnormalities: Asymmetrical bone growth of the face, bone pain and discomfort, loss of mobility, easily broken bones, and crowded, separated, or misaligned teeth [1][2][3]
- Fibrous dysplasia: A disease that destroys normal bone tissue and replaces it with fibrous tissue [4]
- Café-au-lait skin spots: Light-brown birthmarks on the skin [5]
- Early puberty in girls: Menstrual periods may begin in early childhood, long before the breasts or pubic hair develop [6][7]
- Vision and hearing loss: In some cases, MAS can cause vision and hearing loss [8]
It's essential to note that the severity of MAS symptoms can range from mild to severe, and not all individuals with the condition will exhibit all of these signs and symptoms. If you or someone you know is suspected of having McCune-Albright syndrome, it's crucial to consult a medical professional for proper diagnosis and treatment.
References: [1] - Context result 2 [2] - Context result 7 [3] - Context result 9 [4] - Context result 8 [5] - Context result 8 [6] - Context result 6 [7] - Context result 6
Additional Symptoms
- Fibrous dysplasia
- Bone abnormalities
- Café-au-lait skin spots
- Early puberty in girls
- loss of vision
Diagnostic Tests
McCune-Albright Syndrome (MAS) is a rare genetic disorder that affects multiple systems in the body. Diagnostic tests for MAS are crucial to confirm the diagnosis and rule out other conditions.
Tests Used to Diagnose McCune-Albright Syndrome
- A complete medical history and physical examination are essential in evaluating MAS, especially in children [6].
- Blood tests may be done to check for abnormal hormone levels, which can indicate the presence of MAS [1].
- Imaging tests such as X-rays, CT scans, and MRI scans are used to evaluate bone abnormalities and fibrous dysplasia [3][9]. A total body nuclear medicine bone scan is considered the best test for diagnosing fibrous dysplasia [4].
- Genetic testing may be done to confirm the diagnosis of MAS. This involves analyzing the GNAS gene, which is responsible for the condition [5].
Other Diagnostic Tests
- An X-ray and bone scan can reveal whether fibrous dysplasia is present and blood tests will show whether certain hormone levels are elevated [3].
- Other tests that may be done include: MRI of the head; X-rays of the bones. These tests help to evaluate the extent of the condition and rule out other potential causes [8].
Importance of Comprehensive Approach
A comprehensive approach consisting of a detailed history, physical examination, and a battery of tests is required in the diagnostic evaluation of MAS [2]. This ensures that all aspects of the condition are evaluated and a accurate diagnosis is made.
References: [1] Context 1 [2] Context 2 [3] Context 3 [4] Context 4 [5] Context 5 [6] Context 6 [7] Context 7 [8] Context 8 [9] Context 9
Additional Diagnostic Tests
- A complete medical history and physical examination
- Blood tests to check for abnormal hormone levels
- Imaging tests (X-rays, CT scans, MRI scans) to evaluate bone abnormalities and fibrous dysplasia
- Genetic testing to confirm the diagnosis of MAS by analyzing the GNAS gene
- X-ray and bone scan to reveal fibrous dysplasia and elevated hormone levels
- MRI of the head and X-rays of the bones to evaluate the extent of the condition
Treatment
Medications Used to Treat McCune-Albright Syndrome
McCune-Albright syndrome (MAS) is a rare genetic disorder that affects the bones, skin, and endocrine system. While there is no cure for MAS, various medications can help manage its symptoms and complications.
- Bisphosphonates: These drugs can help prevent bone loss and reduce the risk of fractures [1]. They are often recommended by healthcare providers to treat bone growth symptoms associated with MAS.
- Aromatase inhibitors: These medications can help delay early puberty in females affected by MAS [3].
- Testolactone: This drug has been tried with some success in managing estrogen production and related symptoms in individuals with MAS [6].
- Letrozole: Another medication that may be used to manage progressive precocious puberty in females with MAS, particularly if they experience significant symptoms [8].
Other Medications Used to Treat Specific Complications
In addition to these medications, other treatments may be necessary to address specific complications associated with MAS. For example:
- Surgery: Adrenal abnormalities, such as Cushing syndrome, may require surgery to remove the adrenal glands [5].
- Pain management: Medication may be prescribed to manage pain related to bone growth or other symptoms of MAS [7].
Important Note
It's essential to consult with a healthcare provider to determine the best course of treatment for an individual with McCune-Albright syndrome. They can help develop a personalized treatment plan based on the person's specific needs and medical history.
References:
[1] Context 1: Nov 12, 2021 — Healthcare providers may also recommend bisphosphonates, or drugs that help prevent bone loss. [3] Context 3: Medicine to treat early puberty like aromatase inhibitors. [6] Context 6: Drug therapy may be required if females experience progressive precocious puberty. Such drugs include letrozole, which is an... [7] Context 7: ... treatment, but only observation. Drug therapy may be required if females experience progressive precious puberty. [8] Context 8: ... drug therapy may be required if females experience progressive precious puberty. Such drugs include letrozole, which is an...
Recommended Medications
- Bisphosphonates
- Aromatase inhibitors
- testolactone
- Testolactone
- letrozole
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
McCune-Albright syndrome (MAS) is a rare genetic disorder that affects bone growth, skin pigmentation, and hormone balance. When diagnosing MAS, it's essential to consider differential diagnoses, which are conditions that may present with similar symptoms.
Conditions to Consider:
- Neurofibromatosis: A genetic disorder characterized by the growth of non-cancerous tumors on nerve tissue.
- Osteofibrous dysplasia: A rare bone condition that can cause pain and deformity in the affected limb.
- Non-ossifying fibromas: A type of benign bone tumor that can cause pain and swelling.
- Idiopathic central precocious puberty: A condition where children experience early onset puberty without a clear cause.
- Ovarian neoplasm: A rare type of ovarian cancer.
These conditions may present with similar symptoms to MAS, such as: * Abnormal vaginal bleeding * Leg pain or limp * Pathological fractures (broken bones) * Café au lait spots on the skin
Key Points:
- Early recognition and diagnosis of MAS are crucial for effective management.
- A diagnosis of MAS is typically made when at least two phenotypic features associated with activating GNAS1 mutations are present.
- Differential diagnoses should be considered in cases where symptoms suggest MAS, but a definitive diagnosis has not been established.
References: [2] [3] [5]
Additional Differential Diagnoses
- Osteofibrous dysplasia
- Non-ossifying fibromas
- Idiopathic central precocious puberty
- Ovarian neoplasm
- neurofibromatosis 1
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_9485
- owl#annotatedSource
- t412991
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- OMIM mapping confirmed by DO. [SN].
- oboInOwl#hasAlternativeId
- DOID:11345
- oboInOwl#id
- DOID:1858
- core#notation
- DOID:1858
- oboInOwl#hasDbXref
- UMLS_CUI:C0016065
- core#exactMatch
- MESH:D005359
- IAO_0000115
- A syndrome that is characterized by polyostotic fibrous dysplasia, precocious puberty, and café-au-lait spots and has_material_basis_in spontaneous post zygotic missense mutation at ARG201 or Gln227 of the GNAS gene during embryogenesis.
- oboInOwl#hasExactSynonym
- polyostotic fibrous dysplasia
- rdf-schema#label
- McCune Albright syndrome
- rdf-schema#subClassOf
- t413444
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000934
- relatedICD
- http://example.org/icd10/Q78.1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.